drugset / Trial / NCT04398316

High Dose IV Lidocaine vs Hydromorphone for Abdominal Pain in the Emergency Department

NCT04398316

Phase 4 Terminated 4 enrolled Hennepin Healthcare Research Institute
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Intravenous lidocaine will be given at a dose of 2 mg/kg intravenously to patients in the emergency department with a diagnosis of acute abdominal pain. Its efficacy will be compared to 1 mg of intravenous hydromorphone, with a primary endpoint of mean improvement of pain at 90 minutes.

Timeline

Start
2021-02-18
Primary completion
2021-06-30
Completion
2021-06-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydromorphone Other / unclassified 1 mg Intravenous
Subject Lidocaine Other / unclassified 2 mg/kg Intravenous